Publikace UTB
Repozitář publikační činnosti UTB

Controlled drug delivery device for cornea treatment and novel method for its testing

Repozitář DSpace/Manakin

Zobrazit minimální záznam


dc.title Controlled drug delivery device for cornea treatment and novel method for its testing en
dc.contributor.author Urbánek, Pavel
dc.contributor.author Šuly, Pavol
dc.contributor.author Ševčík, Jakub
dc.contributor.author Hanulíková, Barbora
dc.contributor.author Kuřitka, Ivo
dc.contributor.author Šopík, Tomáš
dc.contributor.author Stodůlka, Pavel
dc.relation.ispartof Pharmaceuticals
dc.identifier.issn 1424-8247 Scopus Sources, Sherpa/RoMEO, JCR
dc.date.issued 2023
utb.relation.volume 16
utb.relation.issue 4
dc.type article
dc.language.iso en
dc.publisher MDPI
dc.identifier.doi 10.3390/ph16040505
dc.relation.uri https://www.mdpi.com/1424-8247/16/4/505
dc.subject controlled drug release en
dc.subject drug delivery device en
dc.subject cornea treatment en
dc.description.abstract A new solution for local anesthetic and antibiotic delivery after eye surgery is presented. A contact lens-shaped collagen drug carrier was created and loaded by Levofloxacin and Tetracaine with a riboflavin crosslinked surface layer, thus impeding diffusion. The crosslinking was confirmed by Raman spectroscopy, whereas the drug release was investigated using UV-Vis spectrometry. Due to the surface barrier, the drug gradually releases into the corneal tissue. To test the function of the carrier, a 3D printed device and a new test method for a controlled drug release, which mimics the geometry and physiological lacrimation rate of the human eye, were developed. The experimental setup with simple geometry revealed that the prepared drug delivery device can provide the prolonged release profile of the pseudo-first-order for up to 72 h. The efficiency of the drug delivery was further demonstrated using a dead porcine cornea as a drug recipient, without the need to use live animals for testing. Our drug delivery system significantly surpasses the efficiency of antibiotic and anesthetic eyedrops that would have to be applied approximately 30 times per hour to achieve the same dose as that delivered continuously by our device. en
utb.faculty University Institute
dc.identifier.uri http://hdl.handle.net/10563/1011521
utb.identifier.obdid 43884805
utb.identifier.scopus 2-s2.0-85154587356
utb.identifier.wok 000976992800001
utb.identifier.pubmed 37111260
utb.source j-scopus
dc.date.accessioned 2023-05-24T13:10:16Z
dc.date.available 2023-05-24T13:10:16Z
dc.description.sponsorship Ministerstvo Školství, Mládeže a Tělovýchovy, MŠMT; Ministerstvo Průmyslu a Obchodu, MPO: RP/CPS/2022/007
dc.rights Attribution 4.0 International
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.rights.access openAccess
utb.ou Centre of Polymer Systems
utb.contributor.internalauthor Urbánek, Pavel
utb.contributor.internalauthor Šuly, Pavol
utb.contributor.internalauthor Ševčík, Jakub
utb.contributor.internalauthor Hanulíková, Barbora
utb.contributor.internalauthor Kuřitka, Ivo
utb.contributor.internalauthor Šopík, Tomáš
utb.fulltext.sponsorship This article was supported by project FV40377 funded by the Ministry of Industry and Trade of the Czech Republic. J.Š. especially thanks to project DKRVO–RP/CPS/2022/007 provided by the Ministry of Education, Youth and Sports of the Czech Republic.
utb.wos.affiliation [Urbanek, Pavel; Suly, Pavol; Sevcik, Jakub; Hanulikova, Barbora; Kuritka, Ivo; Sopik, Tomas] Tomas Bata Univ Zlin, Ctr Polymer Syst, Trida Tomase Bati 5678, Zlin 76001, Czech Republic; [Stodulka, Pavel] Gemini Eye Clin, U Gemini 360, Zlin 76001, Czech Republic
utb.scopus.affiliation Centre of Polymer Systems, Tomas Bata University in Zlín, trida Tomase Bati 5678, Zlin, 76001, Czech Republic; Gemini Eye Clinic, U Gemini 360, Zlin, 76001, Czech Republic
utb.fulltext.projects FV40377
utb.fulltext.projects DKRVO–RP/CPS/2022/007
Find Full text

Soubory tohoto záznamu

Zobrazit minimální záznam

Attribution 4.0 International Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je Attribution 4.0 International